hyperadrenal disorders Flashcards
what are the clinical features of Cushing’s?
- too much cortisol
- centripetal obesity
- moon face
- buffalo hump
- proximal myopathy
- hypertension and hypokalaemia
- red striae, think skin
- osteoporosis and diabetes
what are the causes of Cushing’s?
- taking too many steroids
- pituitary dependant Cushing’s disease
- ectopic ACTH (lung cancer)
- adrenal adenoma
what investigations should you carry out to determine cause?
- urinary free cortisol
- blood diurnal cortisol analysis
- low-dose decamethasone suppression test
what would the blood diurnal cortisol analysis show in normal people/cushing’s people?
Normal: cortisol high in morning and low at night
Cushing’s: cortisol high all time
what would the low-dose dexamethasone suppression test should in normal/ Cushing’s?
normal: dexamethasone suppresses cortisol to zero due to feedback inhibition
Cushing’s: any cause will fail to suppress
what are the 2 types of Cushing’s treatment?
- drugs: metyrapone, Ketoconazole
- surgery
what is the MoA of metyrapone?
- inhibits 11 beta hydroxylase
- blocks production of cortisol but raises ACTH secretion
- steroid synthesis in zona fasciculata is stopped at 11-deoxycortisol stage
what are the uses of metyrapone?
- control of Cushing’s prior to surgery
- control of Cushing’s after radiotherapy
what are the unwanted actions of metyrapone?
- hypertension (deoxycortisone accumulates in zona glomerulosa which has aldoesterone like activity)
- Hirsutism: inc. androgen production
what is the MoA of ketoconazole?
inhibits steroidogenesis
what are the uses of ketoconazole?
- treatment and control of symptoms prior to surgery
- orally active
what are the unwanted actions?
liver damage
what is Conn’s syndrome?
- benign adrenal cortical (zona glomerulosa) tumour
- produces aldosterone in excess
- leads to hypertension and hypokalaemia
what is the treatment of Conn’s?
- aldosterone receptor antagonists (Spironolactone)
- surgery
what is the MoA of spironolactone?
- spironolactone converted to several active metabolites including canrenone (competitive antagonist of MR)
- blocks Na reabsorption and K excretion